My watch list
my.bionity.com  
Login  

eGenesis is a gene editing and genome engineering company committed to the development of safe and effective human transplantable organs, tissues and cells to address the global organ crisis.

More about eGenesis
  • News

    Bayer invests USD 50 Million in eGenesis Series B financing round

    eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the development of effective human-compatible organs to address the global organ shortage, successfully completed a USD 100 million Series B financing. The financing was led by Fresenius Medical Care Vent ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE